Eshleman AJ - Search Results

1

Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake.

Bliziotes MM, Eshleman AJ, Zhang XW, Wiren KM. Bliziotes MM, et al. Among authors: eshleman aj. Bone. 2001 Nov;29(5):477-86. doi: 10.1016/s8756-3282(01)00593-2. Bone. 2001. PMID: 11704501

2

[3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.

Johnson RA, Eshleman AJ, Meyers T, Neve KA, Janowsky A. Johnson RA, et al. Among authors: eshleman aj. Synapse. 1998 Sep;30(1):97-106. doi: 10.1002/(SICI)1098-2396(199809)30:1<97::AID-SYN12>3.0.CO;2-M. Synapse. 1998. PMID: 9704886

3

Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.

Eshleman AJ, Carmolli M, Cumbay M, Martens CR, Neve KA, Janowsky A. Eshleman AJ, et al. J Pharmacol Exp Ther. 1999 May;289(2):877-85. J Pharmacol Exp Ther. 1999. PMID: 10215666

4

Drug interactions with the dopamine transporter in cryopreserved human caudate.

Eshleman AJ, Wolfrum K, Mash DC, Christensen K, Janowsky A. Eshleman AJ, et al. J Pharmacol Exp Ther. 2001 Feb;296(2):442-9. J Pharmacol Exp Ther. 2001. PMID: 11160629

5

The role of dopamine and serotonin in regulating bone mass and strength: studies on dopamine and serotonin transporter null mice.

Bliziotes M, Gunness M, Eshleman A, Wiren K. Bliziotes M, et al. J Musculoskelet Neuronal Interact. 2002 Mar;2(3):291-5. J Musculoskelet Neuronal Interact. 2002. PMID: 15758457 Free article.

6

Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine).

Warden SJ, Bliziotes MM, Wiren KM, Eshleman AJ, Turner CH. Warden SJ, et al. Among authors: eshleman aj. Mol Cell Endocrinol. 2005 Oct 20;242(1-2):1-9. doi: 10.1016/j.mce.2005.06.005. Mol Cell Endocrinol. 2005. PMID: 16085354 Review.

7

Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells.

Bliziotes M, Eshleman A, Burt-Pichat B, Zhang XW, Hashimoto J, Wiren K, Chenu C. Bliziotes M, et al. Bone. 2006 Dec;39(6):1313-21. doi: 10.1016/j.bone.2006.06.009. Epub 2006 Aug 1. Bone. 2006. PMID: 16884969 Free PMC article.

8

Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitro.

Janowsky A, Eshleman AJ, Johnson RA, Wolfrum KM, Hinrichs DJ, Yang J, Zabriskie TM, Smilkstein MJ, Riscoe MK. Janowsky A, et al. Among authors: eshleman aj. Psychopharmacology (Berl). 2014 Jul;231(14):2771-83. doi: 10.1007/s00213-014-3446-0. Epub 2014 Feb 2. Psychopharmacology (Berl). 2014. PMID: 24488404 Free PMC article.

9

Characterization of a recombinant human dopamine transporter in multiple cell lines.

Eshleman AJ, Neve RL, Janowsky A, Neve KA. Eshleman AJ, et al. J Pharmacol Exp Ther. 1995 Jul;274(1):276-83. J Pharmacol Exp Ther. 1995. PMID: 7616409

10

Release of dopamine via the human transporter.

Eshleman AJ, Henningsen RA, Neve KA, Janowsky A. Eshleman AJ, et al. Mol Pharmacol. 1994 Feb;45(2):312-6. Mol Pharmacol. 1994. PMID: 7906856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters